Abstract:Cocrystallization of the antiviral drugacyclovir (AYL)with gallic acid, as the first AYL-phenolic acid cocrystal, was directionallyassembled and fully characterized. Integrated theoretical and experimentalexplorations simultaneously improved the physicochemical propertiesand antiviral efficiency of the cocrystal, filling the research blankof AYL cocrystals with synergistic antivirus. Toachieve new breakthroughs in the development of synergisticantiviral medication cocrystals of acyclovir (AYL) with phenolic acids,a cocrystallization-driven strategy for optimizing the physicochemicalproperties and increasing the antiviral efficacy is proposed. Thismethod emphasizes the structural features and medicinal value togetherwith the dominant properties of gallic acid (GLA) to promote bothsolubility and permeability of AYL by cocrystallizing GLA into AYL'slattice; meanwhile, the antiviral ability of ALY can be greatly increasedby activating the antiviral potential of GLA and utilizing the synergisticantiviral activity of both in cocrystal formation. Guided by thisidea, the first AYL-phenolic acid cocrystal, AYL-GLA-2H(2)O, is orientationally constructed and fully characterized. The accuratecocrystal structure revealed by single-crystal X-ray diffraction indicatesthat the entry of GLA into the AYL lattice has disrupted the homodimerof AYL itself, leading to the formation of a hydrophobic heterodimerbetween AYL and GLA molecules, coupled with an aqueous tetramer, thusendowing the cocrystal with both hydrophilic and hydrophobic characteristics.Such structural feature induces a concurrent enhancement in dissolubilityand permeability of the cocrystal compared with the parent medicine.These observations can be strongly supported by density functionaltheory-based theoretical investigations involving molecular electrostaticpotential, Hirshfeld surface, frontier molecular orbital, and Gibbssolvation free energy. Interestingly, the perfected AYL's propertiesalong with the stimulated antiviral activity of GLA enable the twoingredients in the cocrystal to display synergistic antiviral activityagainst the herpes simplex virus with a cooperativity index of lessthan 1, contributing to enhancing the antiviral ability. Thus, thiscontribution not only highlights the effectiveness of combining theorywith experiment to solve AYL's issues via the cocrystallization-drivenmethod but fills in the gaps from previous studies on AYL-phenolicacid cocrystals with synergistic antiviral effects.

Directed Self-Assembly with Gallic Acid Provides First Phenolic Acid Cocrystals for the Antiviral Drug Acyclovir Toward Increasing Pharmaceutical Features and Synergy: A Theoretical and Experimental Integration Research

Supramolecular Self-Assembly of Amantadine Hydrochloride with Ferulic Acid Via Dual Optimization Strategy Establishes a Precedent of Synergistic Antiviral Drug-Phenolic Acid Nutraceutical Cocrystal

Cocrystallization of Amantadine Hydrochloride with Resveratrol: The First Drug–Nutraceutical Cocrystal Displaying Synergistic Antiviral Activity

Supramolecular Self-Assembly of Amantadine Hydrochloride with Ferulic Acid Via Dual Optimization Strategy Establishes a Precedent of Synergistic Antiviral Drug-Phenolic Acid Nutraceutical Cocrystal(vol 146, Pg 3988, 2021)

Self-assembly of antifungal agent 5-fluorocytosine and nutrient trans-p-coumaric acid furnishes a cocrystallization clue with the potential to reduce toxicity and side effects for the drug: a case research of combining theory with experiment

Structure Solution of ACV-GLU Cocrystal by Combined XRD Refinement, 1D Solid State NMR and DFT Calculations

Cocrystals of Penciclovir with Hydroxybenzoic Acids: Synthesis, Crystal Structures, and Physicochemical Evaluation

Simultaneously Enhancing the Solubility and Permeability of Acyclovir by Crystal Engineering Approach

Cocrystallization-driven self-assembly with vanillic acid offers a new opportunity for surmounting fast and excessive absorption issues of antifungal drug 5-fluorocytosine: a combined theoretical and experimental research

Cocrystallization of 5-fluorouracil andl-phenylalanine: the first zwitterionic cocrystal of 5-fluorouracil with amino acid exhibiting perfect <i>in vitro</i>/<i>vivo</i> pharmaceutical properties

Cocrystallization of 5-fluorouracil and L-phenylalanine: The first zwitterionic cocrystal of 5-fluorouracil with amino acid exhibiting the perfected in vitro/vivo pharmaceutical properties

Supramolecular self-assembly with p-coumaric acid offers the first cocrystal for perfecting the physicochemical peculiarity and enhancing antifungal effect of drug bifonazole

A Sulfathiazole–Amantadine Hydrochloride Cocrystal: The First Codrug Simultaneously Comprising Antiviral and Antibacterial Components

Directional Self-Assembly of Ofloxacin and Syringic Acid: the First Salt Cocrystal of Ofloxacin with Phenolic Acid Displays Superior in Vitro/Vivo Biopharmaceutical Property and Enhanced Antibacterial Activity

Directional Self-Assembly of Ofloxacin and Syringic Acid: The First Salt Cocrystal of Ofloxacin with Phenolic Acid Displays Superior In V itro/Vivo Biopharmaceutical Property and Enhanced Antibacterial Activity

A supramolecular adduct of tegafur and syringic acid: the first tegafur-nutraceutical cocrystal with perfected<i>in vitro</i>and<i>in vivo</i>characteristics as well as synergized anticancer activities

Chemoenzymatic Synthesis, Characterization, and Controlled Release of Functional Polymeric Prodrugs with Acyclovir As Pendant

Antiviral Supramolecular Polymeric Hydrogels by Self-Assembly of Tenofovir-Bearing Peptide Amphiphiles

Supramolecular Self-Assembly and Perfected in Vitro/vivo Property of 5-Fluorouracil and Ferulic Acid on the Strength of Double Optimized Strategy: the First 5-Fluorouracial-phenolic Acid Nutraceutical Cocrystal with Synergistic Antitumor Efficacy.

Pharmaceutical cocrystal consisting of ascorbic acid with p-aminobenzoic acid and paracetamol

Lyotropic liquid crystal emulsions of LAVR-289: Influence of internal mesophase structure on cytotoxicity and in-vitro antiviral activity